0
0
34 words
0
Comments
Michelle Rheault, MD, provides additional perspective on the results of the DUPLEX trial, which examined sparsentan in patients with FSGS.
You are the first to view
https://www.hcplive.com/view/understanding-the-duplex-trial-and-sparsentan-in-fsgs-with-michelle-rheault-md
Create an account or login to join the discussion